Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia

Alexandra M. Kane,Cheng Liu,Lochlan J. Fennell,Diane M. McKeone,Catherine E. Bond,Pamela M. Pollock,Graeme Young,Barbara A. Leggett,Vicki L. J. Whitehall

DOI: https://doi.org/10.1038/s41416-021-01339-4

IF: 9.075

2021-03-29

British Journal of Cancer

Abstract:Aspirin reduces the incidence of conventional adenomas driven by <i>APC</i> mutation and thus colorectal cancer. The effect of aspirin on the ~20% of colorectal cancers arising via <i>BRAF</i> mutation is yet to be established.

oncology